Visual assessment of coronary artery calcification on low-dose CT scans provides a significant indicator of cardiovascular death, a study found.
Visual assessment of coronary artery calcification on low-dose CT scans provides a significant indicator of cardiovascular death, a study found.
Coronary artery calcification was assessed on ungated low-dose CT scans of the chest in a cohort of 8782 smokers aged 40 to 85. Each participant received a coronary artery calcification score of 0 to 12. The date and cause of death were obtained through the National Death Index.
The rate of cardiovascular deaths increased with an increasing coronary artery score. For patients with a score of zero, the rate was 1.2%. For patients with a score of one to three, the rate was 1.8%; for patients with a score of seven to 12, the rate was 5.3%. A score of at least four was a significant predictor of cardiovascular death, the researchers said. Follow-up ranged from 0.3 months to 91.9 months with a median of 72.3 months (Radiol 2010;257:541-548).
Even after adjusting for sex, age, and pack-years of smoking, the coronary artery calcification score remained significant.Even after adjusting for sex, age, and pack-years of smoking, the coronary artery calcification score remained significant.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.